CN101704808A - 制备他汀类化合物的内酯化方法 - Google Patents
制备他汀类化合物的内酯化方法 Download PDFInfo
- Publication number
- CN101704808A CN101704808A CN200910191545A CN200910191545A CN101704808A CN 101704808 A CN101704808 A CN 101704808A CN 200910191545 A CN200910191545 A CN 200910191545A CN 200910191545 A CN200910191545 A CN 200910191545A CN 101704808 A CN101704808 A CN 101704808A
- Authority
- CN
- China
- Prior art keywords
- compound
- acid
- formula
- solvent
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 150000001875 compounds Chemical class 0.000 title claims abstract description 38
- 238000007273 lactonization reaction Methods 0.000 title abstract description 12
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 29
- 239000002253 acid Substances 0.000 claims abstract description 24
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims abstract description 16
- 239000013078 crystal Substances 0.000 claims abstract description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 150000002596 lactones Chemical class 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 15
- 150000001243 acetic acids Chemical class 0.000 claims description 15
- 238000002425 crystallisation Methods 0.000 claims description 13
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical group [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- -1 lactone compound Chemical class 0.000 claims description 7
- 150000001457 metallic cations Chemical class 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000001953 recrystallisation Methods 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 239000012429 reaction media Substances 0.000 claims description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 229960005215 dichloroacetic acid Drugs 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims description 2
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims description 2
- 239000002808 molecular sieve Substances 0.000 claims description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 150000005826 halohydrocarbons Chemical class 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 239000003054 catalyst Substances 0.000 abstract description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 3
- 150000001768 cations Chemical class 0.000 abstract 2
- 239000012024 dehydrating agents Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 33
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 12
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 12
- 229960002855 simvastatin Drugs 0.000 description 12
- 239000000539 dimer Substances 0.000 description 10
- 150000003863 ammonium salts Chemical class 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 230000035484 reaction time Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 239000013557 residual solvent Substances 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 238000007171 acid catalysis Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QHYIGPGWXQQZSA-UHFFFAOYSA-N azane;methanesulfonic acid Chemical compound [NH4+].CS([O-])(=O)=O QHYIGPGWXQQZSA-UHFFFAOYSA-N 0.000 description 1
- MVIOINXPSFUJEN-UHFFFAOYSA-N benzenesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)C1=CC=CC=C1 MVIOINXPSFUJEN-UHFFFAOYSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000005144 thermotropism Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910191545A CN101704808A (zh) | 2009-11-20 | 2009-11-20 | 制备他汀类化合物的内酯化方法 |
US13/510,701 US8779167B2 (en) | 2009-11-20 | 2010-11-22 | Method for preparing a statin compound by lactonization |
CA2780183A CA2780183C (en) | 2009-11-20 | 2010-11-22 | A method for preparing a statin compound by lactonization |
PCT/CN2010/078949 WO2011060742A1 (zh) | 2009-11-20 | 2010-11-22 | 制备他汀类化合物的内酯化方法 |
EP10831157.2A EP2502923B1 (en) | 2009-11-20 | 2010-11-22 | A method for preparing a statin compound by lactonization |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910191545A CN101704808A (zh) | 2009-11-20 | 2009-11-20 | 制备他汀类化合物的内酯化方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410251979.XA Division CN104098537A (zh) | 2009-11-20 | 2009-11-20 | 制备他汀类化合物的内酯化方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101704808A true CN101704808A (zh) | 2010-05-12 |
Family
ID=42375069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910191545A Pending CN101704808A (zh) | 2009-11-20 | 2009-11-20 | 制备他汀类化合物的内酯化方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8779167B2 (zh) |
EP (1) | EP2502923B1 (zh) |
CN (1) | CN101704808A (zh) |
CA (1) | CA2780183C (zh) |
WO (1) | WO2011060742A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011060742A1 (zh) * | 2009-11-20 | 2011-05-26 | 北大方正集团有限公司 | 制备他汀类化合物的内酯化方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8742111B1 (en) * | 2013-02-21 | 2014-06-03 | The United States Of America As Represented By The Secretary Of The Army | Synthesis of intermediate anilino methyl esters used in the production of synthetic opioid analgesics |
US9659507B2 (en) * | 2014-06-20 | 2017-05-23 | Craig Barrington | Process for clearing a tooth and illustrating the internal structure |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4582915A (en) | 1983-10-11 | 1986-04-15 | Merck & Co., Inc. | Process for C-methylation of 2-methylbutyrates |
US4820850A (en) | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
US4916239A (en) | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
CA2185961A1 (en) | 1996-09-19 | 1998-03-20 | K.S. Keshava Murthy | Process for producing simvastatin |
EP1398764B1 (en) | 1998-09-30 | 2009-12-23 | Toray Industries, Inc. | Dimensionally-stable polymer film and magnetic medium using the same |
PL346392A1 (en) * | 1999-06-29 | 2002-02-11 | Kaneka Corp | Process for selective lactonization |
AU8030900A (en) * | 1999-10-27 | 2001-05-08 | Merck & Co., Inc. | Lactonization process |
NL1017548C2 (nl) * | 2001-03-09 | 2002-09-10 | Synthon Bv | Een lactonisatie proces. |
KR100407758B1 (ko) * | 2001-08-27 | 2003-12-01 | 씨제이 주식회사 | 스타틴의 제조에 있어서 락톤화 방법 |
CN101704808A (zh) * | 2009-11-20 | 2010-05-12 | 西南合成制药股份有限公司 | 制备他汀类化合物的内酯化方法 |
-
2009
- 2009-11-20 CN CN200910191545A patent/CN101704808A/zh active Pending
-
2010
- 2010-11-22 US US13/510,701 patent/US8779167B2/en not_active Expired - Fee Related
- 2010-11-22 WO PCT/CN2010/078949 patent/WO2011060742A1/zh active Application Filing
- 2010-11-22 EP EP10831157.2A patent/EP2502923B1/en not_active Not-in-force
- 2010-11-22 CA CA2780183A patent/CA2780183C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011060742A1 (zh) * | 2009-11-20 | 2011-05-26 | 北大方正集团有限公司 | 制备他汀类化合物的内酯化方法 |
US8779167B2 (en) | 2009-11-20 | 2014-07-15 | Peking University Founder Group Co., Ltd. | Method for preparing a statin compound by lactonization |
Also Published As
Publication number | Publication date |
---|---|
CA2780183C (en) | 2015-07-07 |
US20120296099A1 (en) | 2012-11-22 |
EP2502923A4 (en) | 2013-04-10 |
CA2780183A1 (en) | 2011-05-26 |
WO2011060742A1 (zh) | 2011-05-26 |
EP2502923B1 (en) | 2015-03-11 |
EP2502923A1 (en) | 2012-09-26 |
US8779167B2 (en) | 2014-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111170855A (zh) | 一种化合物及采用该化合物合成8-羟基-2,2,14,14-四甲基十五烷二酸的方法 | |
CN110330500B (zh) | 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法 | |
MX2012013331A (es) | Purificacion de posaconazol y de intermediarios de posaconazol. | |
CN110950765A (zh) | 一种硫酸特布他林的制备方法 | |
CN113135882A (zh) | 一种一锅法合成玻色因的方法 | |
CN101704808A (zh) | 制备他汀类化合物的内酯化方法 | |
EP3854800B1 (en) | High-yield preparation method for novel vascular leakage blocker | |
CN104098537A (zh) | 制备他汀类化合物的内酯化方法 | |
CN112047915B (zh) | C-糖苷类衍生物新的制备工艺 | |
CN107935912B (zh) | 一种氨氯地平中间体的制备工艺 | |
WO2021070209A1 (en) | Method to purify tris-(3-hydroxybutyrato)-glyceryl ester | |
SU1581220A3 (ru) | Способ получени 4-оксипирролидин-2-он-1-ил-ацетамида | |
CN102675267A (zh) | 盐酸决奈达隆及其中间体的制备方法 | |
CN110878079A (zh) | 一种高纯度依利格鲁司他的制备方法 | |
CN104987325B (zh) | 一种伏立康唑的制备方法 | |
CN105175316B (zh) | 一种制备缓泻剂匹可硫酸钠的方法 | |
KR20150091150A (ko) | 트라보프로스트의 제조 방법 | |
CN103709039A (zh) | Cu-丝光沸石催化合成没食子酸甲(乙)酯的方法 | |
CN112920233A (zh) | 一种改善其可加工性的甲维盐的合成方法 | |
CN110698529A (zh) | 一种依普利酮中间体△9,11烯酯的制备方法 | |
CN114249790B (zh) | 一种甾体化合物的制备方法 | |
CN113683574B (zh) | 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法 | |
WO2022194022A1 (zh) | 一种纳布啡癸二酸酯及其中间体的制备方法 | |
EP4083045A1 (en) | Novel method for synthesizing decursin derivative | |
JP3868599B2 (ja) | アルカノイルオキシ安息香酸の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: PKU INTERNATIONAL HEALTHCARE GROUP CO., LTD. Owner name: SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP., LTD., PK Free format text: FORMER OWNER: SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP. LTD. Effective date: 20110714 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110714 Address after: 19, building 9, building B, Fortune Tower, No. 401121, Honghu East Road, Chongqing, Yubei District Applicant after: PKUCare Southwest Synthetic Pharmaceutical Corp., Ltd. Co-applicant after: PKU International Healthcare Group Co., Ltd. Address before: 19, building 9, building B, Fortune Tower, No. 401121, Honghu East Road, Chongqing, Yubei District Applicant before: Southwest Synthetic Pharmaceutical Corp. Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PKU INTERNATIONAL HEALTHCARE GROUP CO., LTD. PEKIN Free format text: FORMER OWNER: PKU INTERNATIONAL HEALTHCARE GROUP CO., LTD. Effective date: 20121107 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121107 Address after: 19, building 9, building B, Fortune Tower, No. 401121, Honghu East Road, Chongqing, Yubei District Applicant after: PKUCare Southwest Synthetic Pharmaceutical Corp., Ltd. Applicant after: PKU International Healthcare Group Co., Ltd. Applicant after: Peking Founder Group Co., Ltd. Address before: 19, building 9, building B, Fortune Tower, No. 401121, Honghu East Road, Chongqing, Yubei District Applicant before: PKUCare Southwest Synthetic Pharmaceutical Corp., Ltd. Applicant before: PKU International Healthcare Group Co., Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20100512 |